The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR(PDF, 524KB) and Technical Notes(PDF, 752KB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 2.21

All Cancer Sites (Invasive)

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2015
By Race/Ethnicity, Sex and Years Since Diagnosis

Race/Ethnicity Sex Years Since Diagnosis Completeh
0 to <5 5 to <10 10 to <15 15 to <20 20 to <25 25 to <30 0 to <23e 0 to <40e >=40g
All Races b Both Sexes 4,824,178 3,556,622 2,539,024 1,684,805 1,027,788 596,607 13,632,413 14,803,473 308,625 15,112,098
Males 2,376,361 1,810,422 1,245,418 753,977 417,992 193,903 6,604,165 6,969,613 62,881 7,032,494
Females 2,447,817 1,746,200 1,293,606 930,828 609,796 402,704 7,028,248 7,833,860 245,744 8,079,604
White b Both Sexes 4,025,710 3,031,670 2,210,923 1,480,152 918,480 540,313 11,666,940 12,729,733 268,423 12,998,156
Males 1,979,553 1,535,116 1,079,470 659,824 375,525 178,046 5,629,489 5,966,232 59,052 6,025,284
Females 2,046,157 1,496,554 1,131,453 820,328 542,955 362,267 6,037,451 6,763,501 209,371 6,972,872
Black b Both Sexes 514,632 342,402 220,174 134,094 70,121 34,036 1,281,422 1,348,176 19,480 1,367,656
Males 262,708 187,253 118,721 66,073 28,714 9,327 663,469 680,131 1,468 681,599
Females 251,924 155,149 101,453 68,021 41,407 24,709 617,953 668,045 18,012 686,057
Asian/
Pacific
Islander c		 Both Sexes 169,228 110,452 72,608 + + + 411,819 + + +
Males 68,694 45,205 28,003 + + + 161,925 + + +
Females 100,534 65,247 44,605 + + + 249,894 + + +
Hispanic d Both Sexes 368,315 242,030 159,921 + + + 902,692 + + +
Males 166,581 115,241 73,688 + + + 410,630 + + +
Females 201,734 126,789 86,233 + + + 492,062 + + +

Estimated prevalence percent a on January 1, 2015, of the SEERc population diagnosed in the previous 23 years
By Age at Prevalence, Race/Ethnicity and Sex

Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedf
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races c Both Sexes 3.7811% 0.0865% 0.1941% 0.3701% 0.8473% 2.0447% 4.6855% 9.9293% 17.3693% 20.4323% 3.4851%
Males 3.6622% 0.0887% 0.2052% 0.3616% 0.6777% 1.3934% 3.7152% 10.1242% 21.1212% 28.0150% 3.7502%
Females 3.8969% 0.0842% 0.1826% 0.3790% 1.0185% 2.6893% 5.6184% 9.7533% 14.2865% 15.8278% 3.3569%
White c Both Sexes 4.1892% 0.0929% 0.2133% 0.4217% 0.9517% 2.2108% 4.9177% 10.3771% 18.3692% 21.5997% 3.6930%
Males 4.0293% 0.0947% 0.2258% 0.4143% 0.7700% 1.5339% 3.8687% 10.3809% 21.9162% 29.0692% 3.9143%
Females 4.3486% 0.0909% 0.2003% 0.4296% 1.1432% 2.9117% 5.9617% 10.3736% 15.3738% 16.9960% 3.6053%
Black c Both Sexes 2.8380% 0.0663% 0.1367% 0.2350% 0.5867% 1.6488% 4.3786% 10.2966% 17.2001% 17.8801% 3.2624%
Males 3.0539% 0.0692% 0.1382% 0.2256% 0.4453% 1.1497% 4.1103% 12.8086% 24.8125% 29.4374% 4.1671%
Females 2.6415% 0.0634% 0.1352% 0.2442% 0.7119% 2.0842% 4.6132% 8.3256% 11.8842% 12.1149% 2.7161%
Asian/
Pacific
Islander c		 Both Sexes 2.3925% 0.0702% 0.1455% 0.2282% 0.5211% 1.4554% 3.3546% 6.4172% 10.5316% 13.4877% 2.2751%
Males 1.9953% 0.0725% 0.1568% 0.2140% 0.3545% 0.7456% 2.0445% 5.4229% 11.7078% 17.9062% 2.1442%
Females 2.7574% 0.0677% 0.1337% 0.2429% 0.6731% 2.0826% 4.4845% 7.2278% 9.6112% 10.7595% 2.4312%
Hispanic d Both Sexes 1.6731% 0.0796% 0.1822% 0.3083% 0.6346% 1.4346% 3.2777% 6.9337% 12.2446% 14.5043% 2.4854%
Males 1.5011% 0.0842% 0.1992% 0.3187% 0.5131% 0.9227% 2.3494% 6.7139% 15.3604% 21.1148% 2.6914%
Females 1.8476% 0.0749% 0.1645% 0.2970% 0.7641% 1.9653% 4.1819% 7.1251% 9.9048% 10.5024% 2.4164%

Footnotes:

a US 2015 cancer prevalence counts are based on 2015 cancer prevalence proportions from the SEER registries and 1/1/2015 US population estimates based on the average of 2014 and 2015 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 40/23 years.

b Statistics based on SEER 9 Areas.

c Statistics based on SEER 13 Areas excluding the Alaska Native Registry

d Statistics based on NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry.

e Maximum limited-duration prevalence: 40 years for 1975-2015 SEER 9 data; 23 years for 1992-2015 SEER 13 data (excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders.

f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

g Cases diagnosed more than 40 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

h Complete prevalence is obtained by summing 0 to <40 and >=40.

i Age-specific completeness index was approximated using empirical data from historical Connecticut tumor registry.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.